Cargando…

New dimension in therapeutic targeting of BCL-2 family proteins

Proteins of the BCL-2 family control the mitochondrial pathway of apoptosis. Targeting these proteins proves to be an attractive strategy for anticancer therapy. The biological context is based on the fact that BH3-only members of the family are specific antagonists of prosurvival members. This prom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Besbes, Samaher, Mirshahi, Massoud, Pocard, Marc, Billard, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536985/ https://www.ncbi.nlm.nih.gov/pubmed/25970783

Ejemplares similares

Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironment
por: ALTHAWADI, HAMDA, et al.
Publicado: (2015)

Thrombopoietin Secretion by Human Ovarian Cancer Cells
por: Besbes, Samaher, et al.
Publicado: (2017)

Targeting the differentiation of gastric cancer cells (KATO-III) downregulates epithelial-mesenchymal and cancer stem cell markers
por: Shah, Shahid, et al.
Publicado: (2019)

First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
por: Besbes, S, et al.
Publicado: (2015)

Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells
por: AZZAZENE, DALEL, et al.
Publicado: ( 201)

Mitosis in Cancer Cell Increases Immune Resistance via High Expression of HLA-G and PD-L1
por: Ullah, Matti, et al.
Publicado: (2020)

Differentiation of cancer cells upregulates HLA-G and PD-L1
por: Ullah, Matti, et al.
Publicado: (2020)

Injured tissues favor cancer cell implantation via fibrin deposits on scar zones
por: Al dybiat, Iman, et al.
Publicado: (2020)

High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β
por: Ullah, Matti, et al.
Publicado: (2019)

Bcl-B: an “unknown” protein of the Bcl-2 family
por: Pervushin, N. V., et al.
Publicado: (2023)

The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma
por: Shah, Shahid, et al.
Publicado: (2018)

Multi-nanolayer drug delivery using radiofrequency plasma technology
por: Al Dybiat, Iman, et al.
Publicado: (2020)

Fibrin Deposit on the Peritoneal Surface Serves as a Niche for Cancer Expansion in Carcinomatosis Patients
por: Shahid, Shah, et al.
Publicado: (2019)

BCL-2 protein family: attractive targets for cancer therapy
por: Kaloni, Deeksha, et al.
Publicado: (2022)

CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer
por: Pasquier, Jennifer, et al.
Publicado: (2018)

Therapeutic Modulation of Apoptosis: Targeting the BCL-2 Family at the Interface of the Mitochondrial Membrane
por: Nemec, Kathleen N., et al.
Publicado: (2008)

Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?
por: Williams, Michelle M., et al.
Publicado: (2015)

Intrinsically Connected: Therapeutically Targeting the Cathepsin Proteases and the Bcl-2 Family of Protein Substrates as Co-regulators of Apoptosis
por: Soond, Surinder M., et al.
Publicado: (2021)

Bcl-2 family member Bcl-G is not a proapoptotic protein
por: Giam, M, et al.
Publicado: (2012)

VDAC2 and the BCL-2 family of proteins
por: Yuan, Zheng, et al.
Publicado: (2021)

BCL-2 as therapeutic target for hematological malignancies
por: Perini, Guilherme Fleury, et al.
Publicado: (2018)

Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
por: de Jong, Yvonne, et al.
Publicado: (2018)

Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset
por: DUCROS, ELODIE, et al.
Publicado: (2012)

Targeting the Bcl-2 Family in B Cell Lymphoma
por: Adams, Clare M., et al.
Publicado: (2019)

Radio-frequency plasma polymerized biodegradable carrier for in vivo release of cis-platinum
por: Bhatt, Sudhir, et al.
Publicado: (2016)

BCL2DB: database of BCL-2 family members and BH3-only proteins
por: Rech de Laval, Valentine, et al.
Publicado: (2014)

Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria
por: Fan, Ying, et al.
Publicado: (2020)

The Bcl-2 Family in Host-Virus Interactions
por: Kvansakul, Marc, et al.
Publicado: (2017)

Subcellular Localization and Dynamics of the Bcl-2 Family of Proteins
por: Popgeorgiev, Nikolay, et al.
Publicado: (2018)

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
por: Lee, Erinna F., et al.
Publicado: (2019)

Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma
por: Adams, Clare M., et al.
Publicado: (2019)

Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2
por: Gagliardi, Maria, et al.
Publicado: (2022)

BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies
por: Bogenberger, J M, et al.
Publicado: (2014)

Detection of Bcl-2 family member Bcl-G in mouse tissues using new monoclonal antibodies
por: Giam, M, et al.
Publicado: (2012)

Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules
por: Valentini, Elisabetta, et al.
Publicado: (2022)

BCL-G: 20 years of research on a non-typical protein from the BCL-2 family
por: Hartman, Mariusz L., et al.
Publicado: (2023)

Yeast as a tool for studying proteins of the Bcl-2 family
por: Polčic, Peter, et al.
Publicado: (2015)

Defining the role of the Bcl-2 family proteins in Huntington's disease
por: Sassone, J, et al.
Publicado: (2013)

Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence
por: Barriuso, Daniel, et al.
Publicado: (2023)

BCL9/BCL9L in hepatocellular carcinoma: Will it or Wnt it be the next therapeutic target?
por: Moghe, Akshata, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_of43jilgngfsnj67f4m7e262ga